NEW YORK, Aug. 22, 2022 /PRNewswire/ — The latest market analysis report titled Travel Vaccines Market by Disease Type and Geography – Forecast and Analysis 2022-2026 has been recently added to Technavio’s catalog. The report analysts have categorized the global travel vaccines market as a part of the global pharmaceuticals market. Our report provides extensive information on the value chain analysis for the travel vaccines market, which vendors can leverage to gain a competitive advantage during the forecast period. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period. One of the key factors driving the global travel vaccines market growth is the increase in global travel and migration. In addition, changes in the demographic profile of travelers globally are one of the key travel vaccines market trends that are expected to impact the industry positively in the forecast period. However, the absence of coverage for travel vaccines in many health plans is expected to limit the market’s growth during the forecast period.
Latest market research report titled Travel Vaccines Market by Disease Type and Geography – Forecast and Analysis 2022-2026 has been announced by Technavio which is proudly partnering with Fortune 500 companies for over 16 years
For market scope, value chain analysis, and key market dynamics, Read a FREE Sample
Travel Vaccines Market Segmentation Highlights
Regional Opportunities
North America: 42% of the market’s growth will originate from North America during the forecast period. The US is the key market for travel vaccines in North America. Market growth in this region will be faster than the growth of the market in the Rest of World (ROW). Increasing access to vaccines against diseases and a growing number of initiatives to generate awareness about immunization programs will fuel the travel vaccines market growth in North America over the forecast period.
Europe
Asia
Rest Of World (ROW)
Revenue-generating Disease Type Segment
Influenza: The travel vaccines market share growth in the influenza segment will be significant during the forecast period. The growing demand for influenza vaccines by the end-user facilities coupled with the rise in traveling rate will drive the segment growth in the coming years. There are multiple vendors operating in the global travel vaccines market for influenza, some of whom are the top and most well-established players in the vaccines market, such as GlaxoSmithKline Plc, Sanofi SA (Sanofi), and CSL Ltd. (CSL), which contribute significantly to the global travel vaccines market for influenza.
Diptheria
Hepatitis
Others
For more segment-based insights and regional opportunities, Request for Sample Report
The travel vaccines market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market. The travel vaccines market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE are some of the major market participants.
To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Vendors are offering a wide range of offerings to gain a competitive edge in the market. For instance, CSL Ltd. offers the broadest influenza vaccine and a wide range of vaccines and specialty medicines that meet unique, local public health needs. Bharat Biotech Ltd. offers travel vaccines such as BioHib, a lyophilized vaccine that is used for development based on an Indian strain.
Backed with competitive intelligence and benchmarking, our research reports on the travel vaccines market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.
More vendor offerings and their strategic initiatives are available in this PDF Sample Report
Travel Vaccines Market Scope
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. Our travel vaccines market report covers the following areas:
Travel Vaccines Market Highlights
CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will assist travel vaccines market growth during the next five years
Estimation of the travel vaccines market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the travel vaccines market
Analysis of the market’s competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of travel vaccines market vendors
Related Reports:
Vaccines Market by Type and Geography – Forecast and Analysis 2022-2026
Human Combination Vaccines Market by Type and Geography – Forecast and Analysis 2021-2025
Therapeutic Vaccines Market by Type and Geography – Forecast and Analysis 2020-2024
Foot and Mouth Disease Vaccines Market by Product and Geography – Forecast and Analysis 2021-2025
|
Travel Vaccines Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.59% |
|
Market growth 2022-2026 |
$ 2.44 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
7.85 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 42% |
|
Key consumer countries |
US, Germany, UK, Japan, and China |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table Of Contents :
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary – Chart on Incremental Growth
Exhibit 07: Executive Summary – Data Table on Incremental Growth
Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
5 Market Segmentation by Disease Type
5.1 Market segments
Exhibit 24: Chart on Disease Type – Market share 2021-2026 (%)
Exhibit 25: Data Table on Disease Type – Market share 2021-2026 (%)
5.2 Comparison by Disease Type
Exhibit 26: Chart on Comparison by Disease Type
Exhibit 27: Data Table on Comparison by Disease Type
5.3 Influenza – Market size and forecast 2021-2026
Exhibit 28: Chart on Influenza – Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Influenza – Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Influenza – Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Influenza – Year-over-year growth 2021-2026 (%)
5.4 Diptheria – Market size and forecast 2021-2026
Exhibit 32: Chart on Diptheria – Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Diptheria – Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Diptheria – Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Diptheria – Year-over-year growth 2021-2026 (%)
5.5 Hepatitis – Market size and forecast 2021-2026
Exhibit 36: Chart on Hepatitis – Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Hepatitis – Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Hepatitis – Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Hepatitis – Year-over-year growth 2021-2026 (%)
5.6 Others – Market size and forecast 2021-2026
Exhibit 40: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others – Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Disease Type
Exhibit 44: Market opportunity by Disease Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share by geography 2021-2026 (%)
Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America – Market size and forecast 2021-2026
Exhibit 50: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America – Year-over-year growth 2021-2026 (%)
7.4 Europe – Market size and forecast 2021-2026
Exhibit 54: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe – Year-over-year growth 2021-2026 (%)
7.5 Asia – Market size and forecast 2021-2026
Exhibit 58: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia – Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) – Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
7.7 US – Market size and forecast 2021-2026
Exhibit 66: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US – Year-over-year growth 2021-2026 (%)
7.8 Germany – Market size and forecast 2021-2026
Exhibit 70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
7.9 UK – Market size and forecast 2021-2026
Exhibit 74: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK – Year-over-year growth 2021-2026 (%)
7.10 Japan – Market size and forecast 2021-2026
Exhibit 78: Chart on Japan – Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
7.11 China – Market size and forecast 2021-2026
Exhibit 82: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China – Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 86: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Bharat Biotech Ltd.
Exhibit 93: Bharat Biotech Ltd. – Overview
Exhibit 94: Bharat Biotech Ltd. – Product / Service
Exhibit 95: Bharat Biotech Ltd. – Key news
Exhibit 96: Bharat Biotech Ltd. – Key offerings
10.4 CSL Ltd.
Exhibit 97: CSL Ltd. – Overview
Exhibit 98: CSL Ltd. – Business segments
Exhibit 99: CSL Ltd. – Key news
Exhibit 100: CSL Ltd. – Key offerings
Exhibit 101: CSL Ltd. – Segment focus
10.5 GlaxoSmithKline Plc
Exhibit 102: GlaxoSmithKline Plc – Overview
Exhibit 103: GlaxoSmithKline Plc – Business segments
Exhibit 104: GlaxoSmithKline Plc – Key news
Exhibit 105: GlaxoSmithKline Plc – Key offerings
Exhibit 106: GlaxoSmithKline Plc – Segment focus
10.6 Merck and Co. Inc.
Exhibit 107: Merck and Co. Inc. – Overview
Exhibit 108: Merck and Co. Inc. – Business segments
Exhibit 109: Merck and Co. Inc. – Key news
Exhibit 110: Merck and Co. Inc. – Key offerings
Exhibit 111: Merck and Co. Inc. – Segment focus
10.7 Mitsubishi Chemical Holdings Corp.
Exhibit 112: Mitsubishi Chemical Holdings Corp. – Overview
Exhibit 113: Mitsubishi Chemical Holdings Corp. – Business segments
Exhibit 114: Mitsubishi Chemical Holdings Corp. – Key offerings
Exhibit 115: Mitsubishi Chemical Holdings Corp. – Segment focus
10.8 Pfizer Inc.
Exhibit 116: Pfizer Inc. – Overview
Exhibit 117: Pfizer Inc. – Product / Service
Exhibit 118: Pfizer Inc. – Key news
Exhibit 119: Pfizer Inc. – Key offerings
10.9 Sanofi
Exhibit 120: Sanofi – Overview
Exhibit 121: Sanofi – Business segments
Exhibit 122: Sanofi – Key news
Exhibit 123: Sanofi – Key offerings
Exhibit 124: Sanofi – Segment focus
10.10 Serum Institute of India Pvt. Ltd.
Exhibit 125: Serum Institute of India Pvt. Ltd. – Overview
Exhibit 126: Serum Institute of India Pvt. Ltd. – Product / Service
Exhibit 127: Serum Institute of India Pvt. Ltd. – Key offerings
10.11 SK Chemicals Co. Ltd.
Exhibit 128: SK Chemicals Co. Ltd. – Overview
Exhibit 129: SK Chemicals Co. Ltd. – Business segments
Exhibit 130: SK Chemicals Co. Ltd. – Key offerings
Exhibit 131: SK Chemicals Co. Ltd. – Segment focus
10.12 Takeda Pharmaceutical Co. Ltd.
Exhibit 132: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibit 133: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibit 134: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibit 135: Takeda Pharmaceutical Co. Ltd. – Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
11.5 List of abbreviations
Exhibit 142: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
